Schedule

XVIII Simposio Internacional de Resistencia Antimicrobiana | 03 de mar de 2027, 7:00 a. m. – 05 de mar de 2027, 1:00 p. m. Hilton Garden Inn, Barranquilla, Atlantico, Colombia

Get Tickets

mié, 03 de mar

7:00 a. m. - 8:30 a. m.
1 hora 30 minutos
Meet the expert
Amadeus 2
7:00 a. m. - 8:30 a. m.
1 hora 30 minutos
Meet the expert
Amadeus 3
7:00 a. m. - 8:30 a. m.
1 hora 30 minutos
Meet the expert
Amadeus 1
8:55 a. m. - 12:10 p. m.
3 horas 15 minutos
SESSION 1: PRESENT AND FUTURE OF ANTIMICROBIALS AND ANTIMICROBIAL RESISTANCE MECHANISMS
Amadeus 2
9:00 a. m. - 9:30 a. m.
30 minutos
Emerging mechanisms of resistance to new generation inhibitors: the revenge of the Gram-negatives
Amadeus 2
9:30 a. m. - 10:00 a. m.
30 minutos
Changing paradigms: new IDSA/ESCMID guidelines for the diagnosis and management of bacteremia by Staphylococcus aureus
Amadeus 2
10:00 a. m. - 10:30 a. m.
30 minutos
Coffee break
10:30 a. m. - 11:00 a. m.
30 minutos
Treatment of metallo-ß-Lactamase-producing Gram-negative infections
Amadeus 2
11:00 a. m. - 11:30 a. m.
30 minutos
Real world data (RWD) to evaluate the effectiveness of new antimicrobials
Amadeus 2
11:30 a. m. - 12:10 p. m.
40 minutos
Round table: questions & answers
Amadeus 2
12:30 p. m. - 1:45 p. m.
1 hora 15 minutos
Satellite symposium
Amadeus 3
12:30 p. m. - 1:45 p. m.
1 hora 15 minutos
Satellite symposium
Amadeus 1
1:55 p. m. - 7:00 p. m.
5 horas 5 minutos
SESSION 2: NEW GENERATION DIAGNOSTICS: FROM THE LABORATORY TO THE PHYSICIAN
Amadeus 2
2:00 p. m. - 2:30 p. m.
30 minutos
Advances in the integration of molecular diagnostics and therapeutic decisions
Amadeus 2
2:30 p. m. - 3:00 p. m.
30 minutos
Genomic sequencing integrated with the clinic. Are we closer?
Amadeus 2
3:00 p. m. - 3:30 p. m.
30 minutos
Update in the septic patient: from diagnostic to therapeutic decisions
Amadeus 2
3:30 p. m. - 4:00 p. m.
30 minutos
Coffee break
4:00 p. m. - 4:30 p. m.
30 minutos
Computational solutions: for the microbiology laboratory to the antimicrobial stewardship programs (ASP)
Amadeus 2
4:30 p. m. - 5:00 p. m.
30 minutos
Optimization and rapid detection of AMR through advanced laboratory technologies
Amadeus 2
5:00 p. m. - 6:00 p. m.
1 hora
Challenging cases in Gram-negative and Gram-positive superbug infections
Amadeus 2
6:00 p. m. - 6:15 p. m.
15 minutos
OPENING CEREMONY
Amadeus 2
6:15 p. m. - 7:00 p. m.
45 minutos
LECTURE JOHN P. QUINN
Amadeus 2

jue, 04 de mar

7:00 a. m. - 8:30 a. m.
1 hora 30 minutos
Meet the expert
Amadeus 3
7:00 a. m. - 8:30 a. m.
1 hora 30 minutos
Meet the expert
Amadeus 1
7:00 a. m. - 8:30 a. m.
1 hora 30 minutos
Meet the expert
Amadeus 2
8:55 a. m. - 12:10 p. m.
3 horas 15 minutos
SESSION 3: VACCINATION AND ANTIMICROBIAL STEWARDSHIP (AMS)
Amadeus 2
9:00 a. m. - 9:30 a. m.
30 minutos
Precision stewardship: safeguarding the microbiome through safe antimicrobial use
Amadeus 2
9:30 a. m. - 10:00 a. m.
30 minutos
Vaccines and AMS: a mandatory couple to prevent infections, AMR and preserve the effectiveness of antibiotics
Amadeus 2
10:00 a. m. - 10:30 a. m.
30 minutos
Coffee break
10:30 a. m. - 11:00 a. m.
30 minutos
Should vaccination be a mandatory indicator of modern ASP in adult patients?
Amadeus 2
11:00 a. m. - 11:30 a. m.
30 minutos
Vaccines for adults in the 21st-century: innovation, evidence and new opportunities
Amadeus 2
11:30 a. m. - 12:10 p. m.
40 minutos
Round table: questions & answers
Amadeus 2
12:30 p. m. - 1:45 p. m.
1 hora 15 minutos
Satellite symposium
Amadeus 3
12:30 p. m. - 1:45 p. m.
1 hora 15 minutos
Satellite symposium
Amadeus 1
12:30 p. m. - 1:45 p. m.
1 hora 15 minutos
Satellite symposium
Amadeus 2
1:55 p. m. - 5:30 p. m.
3 horas 35 minutos
SESSION 4: BEYOND ANTIMICROBIALS
Amadeus 2
2:00 p. m. - 2:30 p. m.
30 minutos
Phage therapy: is it ready for clinical use?
Amadeus 2
2:30 p. m. - 3:00 p. m.
30 minutos
Hands hygiene: how we can achieve adherence. Punitive versus only educational strategies
Amadeus 2
3:00 p. m. - 3:30 p. m.
30 minutos
Coffee break
3:30 p. m. - 4:00 p. m.
30 minutos
Ideal disinfection: the right product in the right environment for the right bacteria
Amadeus 2
4:00 p. m. - 4:30 p. m.
30 minutos
TBD
Amadeus 2
4:30 p. m. - 5:00 p. m.
30 minutos
Prevention of infections associated with vascular access: beyond CLABSI
Amadeus 2
5:00 p. m. - 5:30 p. m.
30 minutos
Round table: questions & answers
Amadeus 2
5:30 p. m. - 6:30 p. m.
1 hora
Satellite symposium
Amadeus 2

vie, 05 de mar

7:00 a. m. - 8:30 a. m.
1 hora 30 minutos
Meet the expert
Amadeus 3
7:00 a. m. - 8:30 a. m.
1 hora 30 minutos
Meet the expert
Amadeus 2
7:00 a. m. - 8:30 a. m.
1 hora 30 minutos
Meet the expert
Amadeus 1
8:55 a. m. - 12:50 p. m.
3 horas 55 minutos
SESSION 5: INTEGRATED MANAGEMENT OF SPECIAL POPULATIONS
Amadeus 2
9:00 a. m. - 9:30 a. m.
30 minutos
Diagnostic approach to the patient with fungal infections
Amadeus 2
9:30 a. m. - 10:00 a. m.
30 minutos
Fungal therapy in immunocompromised patients: which, when and for how long
Amadeus 2
10:00 a. m. - 10:30 a. m.
30 minutos
Coffee break
10:30 a. m. - 11:00 a. m.
30 minutos
Individualized doses of β-lactams in critically ill patients: continuous vs intermittent infusion in renal impairment
Amadeus 2
11:00 a. m. - 11:30 a. m.
30 minutos
Therapeutic approach and treatment duration for bacteremia and pneumonia in immunocompromised patients
Amadeus 2
11:30 a. m. - 12:00 p. m.
30 minutos
Clinical evidence versus PK/PD of new antibiotics in special populations: can we use them off label?
Amadeus 2
12:00 p. m. - 12:30 p. m.
30 minutos
Round table: questions & answers
Amadeus 2
12:30 p. m. - 12:45 p. m.
15 minutos
Closing of the event
Amadeus 2

Schedule

mié, 03 de mar

Meet the expert

Meet the expert

Meet the expert

SESSION 1: PRESENT AND FUTURE OF ANTIMICROBIALS AND ANTIMICROBIAL RESISTANCE MECHANISMS

Emerging mechanisms of resistance to new generation inhibitors: the revenge of the Gram-negatives

Changing paradigms: new IDSA/ESCMID guidelines for the diagnosis and management of bacteremia by Staphylococcus aureus

Coffee break

Treatment of metallo-ß-Lactamase-producing Gram-negative infections

Real world data (RWD) to evaluate the effectiveness of new antimicrobials

Round table: questions & answers

Satellite symposium

Satellite symposium

SESSION 2: NEW GENERATION DIAGNOSTICS: FROM THE LABORATORY TO THE PHYSICIAN

Advances in the integration of molecular diagnostics and therapeutic decisions

Genomic sequencing integrated with the clinic. Are we closer?

Update in the septic patient: from diagnostic to therapeutic decisions

Coffee break

Computational solutions: for the microbiology laboratory to the antimicrobial stewardship programs (ASP)

Optimization and rapid detection of AMR through advanced laboratory technologies

Challenging cases in Gram-negative and Gram-positive superbug infections

OPENING CEREMONY

LECTURE JOHN P. QUINN

jue, 04 de mar

Meet the expert

Meet the expert

Meet the expert

SESSION 3: VACCINATION AND ANTIMICROBIAL STEWARDSHIP (AMS)

Precision stewardship: safeguarding the microbiome through safe antimicrobial use

Vaccines and AMS: a mandatory couple to prevent infections, AMR and preserve the effectiveness of antibiotics

Coffee break

Should vaccination be a mandatory indicator of modern ASP in adult patients?

Vaccines for adults in the 21st-century: innovation, evidence and new opportunities

Round table: questions & answers

Satellite symposium

Satellite symposium

Satellite symposium

SESSION 4: BEYOND ANTIMICROBIALS

Phage therapy: is it ready for clinical use?

Hands hygiene: how we can achieve adherence. Punitive versus only educational strategies

Coffee break

Ideal disinfection: the right product in the right environment for the right bacteria

TBD

Prevention of infections associated with vascular access: beyond CLABSI

Round table: questions & answers

Satellite symposium

vie, 05 de mar

Meet the expert

Meet the expert

Meet the expert

SESSION 5: INTEGRATED MANAGEMENT OF SPECIAL POPULATIONS

Diagnostic approach to the patient with fungal infections

Fungal therapy in immunocompromised patients: which, when and for how long

Coffee break

Individualized doses of β-lactams in critically ill patients: continuous vs intermittent infusion in renal impairment

Therapeutic approach and treatment duration for bacteremia and pneumonia in immunocompromised patients

Clinical evidence versus PK/PD of new antibiotics in special populations: can we use them off label?

Round table: questions & answers

Closing of the event

Universidad El Bosque